Stock Analysis: Pfizer Inc (PFE)

Stock Analysis for Pfizer Inc (PFE)

The Interpreter
Hey Friend, I'm analysing PFIZER INC (PFE), and it is between the Support of $ 25.45 (PivotS2) and the Resistance of $ 26.06 (PivotS1). The stock is falling and may come close and reach $ 25.45 soon.

Pfizer Inc (PFE)

$ 25.41 -1.1%

Last Close 17-Apr-24

Trade PFE Now

Supports

Next Support: $ 25.45

Pivot S2: $ 25.45
Triangle Level (2): $ 25.34

Resistances

Next Resistance: $ 26.06

Pivot S1: $ 26.06
Fibonacci -100%: $ 32.13
Triangle Level (2): $ 30.21

Supports and Resistances

Click to Enlarge

Candlesticks, "48-hour" Trade Signals +

Date	Price $	Result %	Candle Name	Side
001 10 Apr 2024	Sell Price: 26.32	Profit: Open Day2 ($ 26.25)	Abandoned Baby	Sell
002 28 Mar 2024	Sell Price: 27.75	Profit: Close Day1 ($ 27.72)	Engulfing	Sell
003 28 Mar 2024	Sell Price: 27.75	Profit: Close Day1 ($ 27.72)	Dark Cloud Cover	Sell
004 26 Feb 2024	Sell Price: 27.18	Profit: Open Day1 ($ 27.12)	Abandoned Baby	Sell
005 23 Feb 2024	Buy Price: 27.76	Loss: Close Day2 ($ 26.89)	Abandoned Baby	Buy
006 29 Sep 2023	Buy Price: 33.17	Profit: Close Day1 ($ 33.94)	Abandoned Baby	Buy
007 05 Sep 2023	Sell Price: 35.38	Profit: Open Day1 ($ 35.26)	Engulfing	Sell
008 26 Jul 2023	Buy Price: 37.21	Loss: Close Day2 ($ 36.07)	Piercing Line	Buy
009 25 Jul 2023	Sell Price: 37.06	Profit: Open Day1 ($ 36.87)	Abandoned Baby	Sell
010 09 Jun 2023	Sell Price: 38.97	Loss: Close Day2 ($ 40.28)	Engulfing	Sell
011 02 May 2023	Sell Price: 39.06	Profit: Close Day1 ($ 38.45)	Dark Cloud Cover	Sell
012 21 Apr 2023	Buy Price: 40.21	Loss: Close Day2 ($ 39.33)	Abandoned Baby	Buy
013One Year Average	Both Sides Result for 12 Signals	Loss: $ -2.32 ($ -0.19 / Signal) -7.0% Gross in 1 Year	All of Them	Buy + Sell

Trading Rules for Candlesticks Patterns.

Buy or Sell on the same day of the signal, during the after-hours trading session.
Watch the Opening and Closing of the next 2 days (4 in total).
Immediately exit the Trade when one of them (Open or Close, Day 1 or 2) gives you a profit.
The table above will show the first Profit opportunity, but not in real-time. Therefore, you must watch the market in real-time with your broker.

Remember: The returns an asset made in the past don't mean that future returns will be the same.

Backtest Lab, "Buy The Dip" Trade Signals +

Find The Lastest Buy Signals for PFE Below.

Please Subscribe to See
The Latest Trade Signals

Moving Averages +

Bought Moving Averages

Sold Moving Averages

Simple Moving Averages (SMA) Period	Value $	Signal	Exponential Moving Averages (EMA) Period	Value $	Signal
2	25.56	SELL	2	25.54	SELL
3	25.67	SELL	3	25.64	SELL
5	25.84	SELL	5	25.82	SELL
8	26.11	SELL	8	26.06	SELL
13	26.52	SELL	13	26.36	SELL
21	26.93	SELL	21	26.66	SELL
34	27.07	SELL	34	26.93	SELL
55	27.16	SELL	55	27.29	SELL
90	27.62	SELL	90	28.02	SELL
200	30.85	SELL	200	30.95	SELL

Company Info +

Name & IPO

Pfizer Inc
IPO: 1944-01-17

Stock Ticker & Exchange

Ticker: PFEIndices: S&P 500,
Exchange: New York Stock Exchange, Inc. (US - USD)

Contact

Website: https://www.pfizer.com/
Phone:

Stock Type

Common Stock

SIC Office

Life Sciences ()

Industry

Pharmaceutical Preparations

EIN

Fiscal Year End

State of Inc.

Balance Sheets +

in USD millions (if not decimal) - Dictionary

	Year	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
1	Assets +	154,229	167,489	159,422	171,797	171,615	167,460	169,274	172,101	185,798	188,002	195,014	212,949	111,148	3,406	1,827
2	Real Estate Investment Property +	0	0	0	0	0	0	0	557	597	737	803	937	0	0	0
3	Real Estate Investment Property +	0	0	0	0	0	0	0	557	597	737	803	937	0	0	0
4	Investments in and Advance to Affiliates +	16,856	17,133	181	0	270	0	0	0	0	0	0	0	0	0	0
5	Cash and Cash Equivalents +	1,784	1,305	1,139	1,342	2,595	3,641	3,343	2,183	10,389	3,182	1,735	1,978	2,122	3,406	1,827
6	Property +	13,900	13,967	13,385	13,865	13,318	13,766	11,762	12,397	14,461	15,921	17,607	22,780	13,287	0	0
7	Property +	28,711	30,756	29,977	30,037	28,125	27,268	24,988	25,678	27,882	29,237	32,298	33,924	0	0	0
8	Intangible Assets +	28,471	35,370	35,211	48,741	52,648	40,356	35,166	39,385	46,013	51,184	57,558	68,015	17,721	0	0
9	Finite-Lived Intangible Assets +	23,896	26,387	31,045	36,562	35,664	32,165	27,506	31,558	37,427	42,218	43,829	49,549	0	0	0
10	Liabilities and Equity +	154,229	167,489	159,422	171,797	171,615	167,460	169,274	172,101	185,798	188,002	195,014	212,949	111,148	65,124	71,432
11	Liabilities +	90,756	104,042	95,664	100,141	111,776	102,463	97,652	95,481	104,120	105,381	106,749	122,503	53,408	0	0
12	Debt and Lease Obligation +	701	14,775	4,066	6,420	6,473	0	0	3,000	2,700	0	0	0	0	0	0
13	Stockholders' Equity +	63,473	63,447	63,758	71,656	59,840	64,998	71,622	76,620	81,678	82,621	88,265	90,446	57,740	65,124	71,432
14	Stockholders' Equity Attributable to Parent +	63,238	63,143	63,407	71,308	59,544	64,720	71,301	76,307	81,260	82,190	87,813	90,014	57,556	0	0
15	Stockholders' Equity +	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0	0
16	Preferred Stock +	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
17	Common Stock +	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0.05	0	0
18	Partners' Capital +	96,770	97,670	89,554	85,291	71,774	71,993	72,176	69,732	54,240	46,210	42,716	40,426	49,142	0	0
19	Partners' Capital +	96,770	97,670	89,554	85,291	71,774	71,993	72,176	69,732	54,240	46,210	42,716	40,426	49,142	0	0
20	Limited Liability Company (LLC) Members' Equity +	85,082	86,030	78,279	75,970	60,738	62,471	64,860	66,461	48,287	42,081	39,276	40,978	44,573	0	0
21	Limited Liability Company (LLC) Members' Equity +	85,082	86,030	78,279	75,970	60,738	62,471	64,860	66,461	48,287	42,081	39,276	40,978	44,573	0	0
22	Current Assets +	35,067	32,803	49,926	41,141	38,949	43,804	57,702	56,244	61,415	60,817	60,468	61,670	43,076	0	0
23	Cash +	11,004	8,525	17,694	18,650	15,255	19,649	32,779	30,225	22,319	23,270	26,277	23,991	21,609	0	0
24	Current Receivables +	7,930	8,724	8,025	8,221	8,225	8,176	8,669	9,357	12,378	13,109	15,079	15,840	9,782	0	0
25	Inventory +	8,046	8,283	7,508	7,578	6,783	7,513	5,663	6,166	7,063	6,610	8,405	12,403	4,381	0	0
26	Current Disposal Group +	167	21	9,725	12	801	9	0	0	1,472	550	0	0	0	0	0
27	Long-Term Assets +	55,539	64,416	56,210	59,179	57,772	51,741	45,582	46,115	47,905	44,569	43,432	42,376	21,464	0	0
28	Long-term Investments and Receivables +	20,262	3,014	2,767	7,015	7,116	15,999	17,518	16,406	14,149	9,457	9,748	13,122	11,478	0	0
29	Long-Term Disposal Group +	0	13,427	0	0	0	0	0	0	139	0	0	0	0	0	0
30	Current Liabilities +	25,920	37,304	31,858	30,427	31,115	29,399	21,631	23,366	28,619	28,909	28,609	37,225	27,009	0	0
31	Long-Term Other Undisclosed Liabilities	0	0	0	0	0	34,997	35,244	0	0	26,791	27,884	27,474	8,798	0	0
32	Long-Term Liabilities +	61,105	61,575	57,904	62,284	72,488	73,064	76,021	39,222	50,465	76,472	78,140	85,278	26,399	0	0
33	Increase (Decrease) in Stockholders' Equity [Roll Forward] +	-110,988	-110,801	-101,610	-89,425	-84,364	-79,252	-73,021	-67,923	-40,121	-31,801	-22,712	-21,632	-57,391	0	0
34	Treasury Stock Transactions +	-110,988	-110,801	-101,610	-89,425	-84,364	-79,252	-73,021	-67,923	-40,121	-31,801	-22,712	-21,632	-57,391	0	0
35	Treasury Stock +	-110,988	-110,801	-101,610	-89,425	-84,364	-79,252	-73,021	-67,923	-40,121	-31,801	-22,712	-21,632	-57,391	0	0
36	Current Other Assets +	3,438	2,600	2,461	2,289	2,249	2,163	2,750	3,613	3,567	0	0	0	0	0	0
37	Total Current Assets +	35,067	32,803	49,926	41,141	38,949	43,804	57,702	56,244	61,415	60,817	60,468	61,670	43,076	0	0
38	Long-Term Inventory +	890	714	618	683	683	594	425	463	761	800	0	0	0	0	0
39	Operating Lease +	1,393	1,313	0	0	0	0	0	0	0	0	0	0	0	0	0
40	Goodwill +	49,577	58,653	53,411	55,952	54,449	48,242	42,069	42,519	44,672	44,569	43,432	42,376	21,464	0	0
41	Long-Term Other Assets +	4,569	4,450	2,799	3,227	3,323	3,499	3,513	3,596	3,233	0	0	0	0	0	0
42	Total Assets +	154,229	167,489	159,422	171,797	171,615	167,460	169,274	172,101	185,798	188,002	195,014	212,949	111,148	0	0
43	Total Liabilities +	90,756	104,042	95,664	100,141	111,776	102,463	97,652	95,481	104,120	105,381	106,749	122,503	53,408	0	0
44	Stockholders' Equity Attributable to Noncontrolling Interest +	235	303	351	348	296	278	321	313	418	431	452	432	184	0	0
45	Total Stockholders' Equity +	63,473	63,447	63,758	71,656	59,840	64,998	71,622	76,620	81,678	82,621	88,265	90,446	57,740	65,124	71,432
46	Total Liabilities and Equity +	154,229	167,489	159,422	171,797	171,615	167,460	169,274	172,101	185,798	188,002	195,014	212,949	111,148	0	0

Income Statement +

in USD millions (if not decimal) - Dictionary

	Year	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007
1	Total Cost of Goods and Services Sold +	-8,692	-10,219	-11,248	-11,228	-12,322	0	0	-9,586	-11,334	-14,076	-14,788	-8,888	-8,112	-11,239
2	Research and Development Expense (Excluding Acquired in Process Cost) +	9,405	8,650	8,006	7,657	7,872	7,690	8,393	6,678	7,870	9,074	9,483	7,845	7,945	8,089
3	Research and Development in Process +	0	0	0	0	0	0	0	0	0	0	9,608	7,913	8,578	8,372
4	Gain (Loss) Related to Litigation Settlement +	28	554	157	240	510	975	0	-1,342	0	0	0	0	0	0
5	Business Combination +	62	865	417	545	951	1,194	80	-1,198	405	725	1,001	569	0	0
6	Insurance Recoveries +	0	815	0	0	0	0	0	0	0	0	0	0	0	0
7	Other Cost and Expense +	0	0	0	0	0	0	0	-1,251	555	867	0	0	0	0
8	Total Selling-General and Administrative Expense +	11,615	14,350	14,455	14,784	14,837	14,809	14,097	14,355	16,616	18,832	18,973	14,875	14,537	15,626
9	Gain (Loss) on Disposition of Property Plant Equipment +	0	0	0	0	0	0	0	320	52	15	243	188	14	0
10	Total Gain (Loss) on Disposition of Property Plant Equipment +	0	0	60	52	0	0	0	0	0	0	0	0	0	0
11	Sale and Leaseback Transaction +	3	-29	0	0	0	0	0	0	0	0	0	0	0	0
12	Total Gain (Loss) on Disposition of Assets +	240	-60	-71	45	-51	0	0	0	0	0	0	0	0	0
13	Disposal Group +	0	0	1	-55	-1,712	0	0	0	0	-15	155	670	0	0
14	Royalty Income +	770	648	495	499	905	0	0	0	0	0	0	0	0	0
15	Investment Income +	73	226	333	391	470	471	425	403	382	0	0	0	0	0
16	Total Investment Income +	0	0	0	0	0	0	0	0	383	456	400	746	1,288	0
17	Net Periodic Defined Benefits Expense (Reversal of Expense) +	236	-64	288	-101	-139	0	0	0	0	0	0	0	0	0
18	Total Other Nonoperating Income (Expense) +	-669	-3,578	-2,116	-1,315	-3,655	-2,860	-1,009	532	-139	-139	147	-67	-48	0
19	Total Interest Expense +	1,449	1,574	1,316	1,270	1,186	1,199	1,360	1,414	1,524	1,681	1,797	1,233	516	0
20	Total Gain (Loss) on Extinguishment of Debt +	0	138	3	999	312	0	0	0	0	0	0	0	0	0
21	Total Income (Loss) from Continuing Operations before Equity Method Investments +	0	0	0	0	8,351	8,965	12,240	15,716	11,242	0	9,422	10,827	9,694	9,278
22	Income (Loss) from Equity Method Investments +	0	0	0	0	0	-45	-86	0	0	0	0	0	0	0
23	Total Income (Loss) from Continuing Operations before Income Taxes +	7,497	17,682	11,885	12,305	8,351	8,965	12,240	15,716	12,080	12,304	9,471	10,674	0	0
24	Income Tax Expense (Benefit) +	-477	-1,384	-706	9,049	-1,123	-1,990	-3,120	-4,306	-2,562	-3,909	-1,153	-2,197	-1,645	-1,023
25	Total Income (Loss) from Continuing Operations +	6,544	14,914	10,473	30,402	6,106	4,985	5,999	7,104	6,956	4,486	7,165	6,433	6,404	7,232
26	Discontinued Operation +	0	0	0	0	0	20	-9	408	414	487	-50	0	0	0
27	Discontinued Operation +	0	0	0	0	0	22	-12	508	531	624	-81	0	0	0
28	Total Discontinued Operation +	0	4	10	-1	16	17	-6	308	297	350	-19	97	0	0
29	Discontinued Operation +	0	0	0	0	0	-6	51	10,446	7,123	1,688	-11	0	6	-168
30	Discontinued Operation +	0	0	0	0	0	0	47	10,538	9,463	2,072	0	0	0	0
31	Total Discontinued Operation +	0	0	0	3	0	-6	55	10,354	4,783	1,304	-11	17	0	0
32	Discontinued Operation +	0	0	0	0	0	0	0	0	7,123	1,688	-11	-15	0	0
33	Total Income (Loss) from Discontinued Operations +	2,631	4	10	2	17	11	48	10,662	5,080	1,654	-30	14	78	-69
34	Total Net Income (Loss) +	9,652	16,302	11,188	21,355	7,246	6,986	9,168	22,072	14,598	10,049	8,288	8,644	8,127	8,186
35	Total Net Income (Loss) Attributable to Noncontrolling Interest +	-36	-29	-36	-47	-31	-26	-32	-69	-28	-40	-31	-9	-23	-42
36	Total Net Income (Loss) Attributable to Parent +	9,616	16,273	11,153	21,308	7,215	6,960	9,135	22,003	14,570	10,009	8,257	8,635	8,104	8,144
37	Preferred Stock Dividends +	0	1	1	1	1	1	1	2	2	0	0	0	0	0
38	Total Net Income (Loss) Available to Common Stockholders +	9,616	16,272	11,152	21,307	7,214	6,959	9,134	22,001	14,568	10,007	8,255	8,633	8,101	0
39	Income (Loss) from Continuing Operations +	7,021	16,298	11,179	21,353	7,229	6,975	9,119	11,410	9,518	8,395	8,318	8,630	8,049	8,255
40	Income (Loss) from Continuing Operations +	0	16,327	11,215	21,400	7,260	7,001	9,151	11,440	9,546	0	0	0	0	0
41	Total Income (Loss) from Continuing Operations +	14,006	32,596	22,358	42,706	14,458	13,950	18,238	22,820	19,036	16,750	16,605	17,251	16,075	0
42	Income (Loss) from Discontinued Operations +	2,631	4	10	2	17	11	48	10,662	5,080	1,654	-30	14	78	-69
43	Income (Loss) from Discontinued Operations +	0	0	0	0	0	0	0	10,701	0	0	0	0	0	0
44	Total Income (Loss) from Discontinued Operations +	2,631	4	10	2	17	11	48	10,623	5,577	2,189	0	0	0	0
45	Income (Loss) from Continuing Operations +	1.26	2.92	1.90	3.57	1.18	1.13	1.43	1.67	1.27	1.07	1.03	1.23	1.19	1.19
46	Total Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations +	0.47	0.98	1.25	0	0	0	0.01	1.56	0.68	0.21	0.01	0.02	0.01	-0.01
47	Total Earnings Per Share +	1.73	2.92	1.90	3.57	1.18	1.13	1.44	3.23	1.96	1.28	1.03	1.23	1.20	1.18
48	Income (Loss) from Continuing Operations +	1.26	2.92	1.90	3.57	1.18	1.13	1.43	1.67	1.27	1.07	1.03	1.23	1.19	1.19
49	Income (Loss) from Continuing Operations +	1.24	2.87	1.86	3.52	1.17	1.11	1.41	1.65	1.26	1.06	1.03	1.23	1.19	1.18
50	Total Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations +	0.47	0.96	1.23	0	0	0	0.01	1.54	0.68	0.21	0.01	0.02	0.01	-0.01
51	Total Earnings Per Share +	1.71	2.87	1.87	3.52	1.17	1.11	1.42	3.19	1.94	1.27	1.02	1.23	1.20	1.17
52	Common Stock Dividends +	1.53	1.46	1.38	1.30	1.22	0.30	0	0	0	0	0	0	0	0
53	Common Stock Dividends +	0	0	0	2.58	2.42	1.42	1.04	0.96	0.88	0.80	0.72	0	0	0

Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.